Key Highlights
- Integration of McRoberts’ 71 endpoints into Empatica’s portfolio, now totaling over 200 digital biomarkers.
- Enhanced features include activity monitoring, energy expenditure, and sleep movements.
- Introduction of key Functional Mobility Assessments like the sit-to-stand and gait tests.
Source: Business Wire
Notable Quotes
- “This partnership shows a maturing digital health industry. Established players are joining forces to provide a one-stop solution to sponsors across the world. You can get the best medical technology and validated measures with a long clinical history in the same place: this means less setup time, costs and patient burden,” – Matteo Lai, CEO & Co-Founder at Empatica
- “Combining our mobility analytics with their versatile platform and extensive array of physiological and behavioral biomarkers promises immense benefits for both our customers,” – Martijn Niessen, CEO at McRoberts
SoHC's Take
The partnership between Empatica and McRoberts marks a significant milestone in the digital health industry, showcasing a strategic expansion of Empatica’s FDA-cleared platform. By incorporating McRoberts’ advanced mobility assessments, Empatica not only broadens its monitoring capabilities but also strengthens its position as a comprehensive provider in the health tech ecosystem. This collaboration highlights the ongoing trend of consolidation and integration within the health tech field, promising enhanced efficiency and broader application possibilities in clinical and research settings.
